Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development Post author: Post published:June 17, 2024 Post category:uncategorized Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays. You Might Also Like Antonin (Tony) de Fougerolles appointed as new Chair of etherna July 10, 2024 Computational tools reveal 3D structures of viral proteins August 27, 2024 Brain activity reveals how autistic teens mask their diagnosis July 21, 2025